According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.32 B. an increase over its 2022 earnings that were of -$0.98 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.32 B | -67.84% |
2022 | -$0.98 B | 36.93% |
2021 | -$0.71 B | -8.04% |
2020 | -$0.78 B | -15.66% |
2019 | -$0.92 B | 12.23% |
2018 | -$0.82 B | 62.91% |
2017 | -$0.51 B | 17.78% |
2016 | -$0.43 B | 43.44% |
2015 | -$0.3 B | 60.69% |
2014 | -$0.19 B | 98.2% |
2013 | -$92.95 M | |
2011 | -$54.82 M | 27.48% |
2010 | -$43.01 M | -10.92% |
2009 | -$48.28 M | 95.77% |
2008 | -$24.66 M | |
2006 | -$39.51 M | -9.13% |
2005 | -$43.48 M | 34.74% |
2004 | -$32.27 M | 36.79% |
2003 | -$23.59 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Novartis NVS | $9.43 B | -3,122.13% | ๐จ๐ญ Switzerland |
Sanofi SNY | $8.39 B | -2,788.26% | ๐ซ๐ท France |
Regeneron Pharmaceuticals REGN | $4.19 B | -1,444.65% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | -$0.53 B | 66.54% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | -$29.44 M | -90.58% | ๐บ๐ธ USA |
OPKO Health
OPK | -$0.19 B | -40.98% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $0.40 B | -229.68% | ๐ฎ๐ฑ Israel |
Arrowhead Pharmaceuticals
ARWR | -$0.29 B | -9.53% | ๐บ๐ธ USA |